Literature DB >> 24674141

Glomerular expression of myxovirus resistance protein 1 in human mesangial cells: possible activation of innate immunity in the pathogenesis of lupus nephritis.

Shojiro Watanabe1, Tadaatsu Imaizumi, Kazushi Tsuruga, Tomomi Aizawa, Tatsuya Ito, Tomoh Matsumiya, Hidemi Yoshida, Kensuke Joh, Etsuro Ito, Hiroshi Tanaka.   

Abstract

Since viral infections activate type I interferon (IFN) pathways and cause subsequent release of IFN-dependent proinflammatory chemokines and cytokines, the innate immune system plays an important role in the pathogenesis of lupus nephritis (LN). It has been reported that human myxovirus resistance protein 1 (Mx1), a type I IFN-dependent transcript, acts against a wide range of RNA viruses. Although the expression of Mx1 in biopsy specimens obtained from patients with dermatomyositis and cutaneous lupus has been described, the expression of Mx1 in human mesangial cells (MCs) has remained largely unknown. We treated normal human MCs in culture with polyinosinic-polycytidylic acid (poly IC), an authentic double-stranded RNA, and analyzed the expression of Mx1 by reverse transcription-polymerase chain reaction and western blotting. To elucidate the poly IC-signalling pathway, we subjected the cells to RNA interference against IFN-β. We also conducted an immunofluorescence study to examine mesangial Mx1 expression in biopsy specimens from patients with LN. Poly IC-induced Mx1 expression in MCs are shown both time- and dose-dependently, and RNA interference against IFN-β inhibited poly IC-induced Mx1 expression. Intense glomerular Mx1 expression was observed in biopsy specimens from patients with LN, whereas negative staining occurred in specimens from patients with IgA nephropathy or purpura nephritis. These preliminary observations support, at least in part, the theory of innate immune system activation in the pathogenesis of LN.
© 2013 Asian Pacific Society of Nephrology.

Entities:  

Keywords:  human myxovirus resistance protein 1; interferon-β; lupus nephritis; mesangial cell

Mesh:

Substances:

Year:  2013        PMID: 24674141     DOI: 10.1111/nep.12155

Source DB:  PubMed          Journal:  Nephrology (Carlton)        ISSN: 1320-5358            Impact factor:   2.506


  10 in total

1.  Identification of Novel EZH2 Targets Regulating Osteogenic Differentiation in Mesenchymal Stem Cells.

Authors:  Sarah Hemming; Dimitrios Cakouros; Kate Vandyke; Melissa J Davis; Andrew C W Zannettino; Stan Gronthos
Journal:  Stem Cells Dev       Date:  2016-06-07       Impact factor: 3.272

Review 2.  Treatment of pediatric-onset lupus nephritis: a proposal of optimal therapy.

Authors:  Hiroshi Tanaka; Kensuke Joh; Tadaatsu Imaizumi
Journal:  Clin Exp Nephrol       Date:  2017-03-03       Impact factor: 2.801

Review 3.  Targeting of type I interferon in systemic autoimmune diseases.

Authors:  Mary K Crow; Mikhail Olferiev; Kyriakos A Kirou
Journal:  Transl Res       Date:  2014-10-16       Impact factor: 7.012

4.  Toll-like receptor 3 signaling contributes to the expression of a neutrophil chemoattractant, CXCL1 in human mesangial cells.

Authors:  Tadaatsu Imaizumi; Tomomi Aizawa; Chihiro Segawa; Michiko Shimada; Kazushi Tsuruga; Shogo Kawaguchi; Tomoh Matsumiya; Hidemi Yoshida; Kensuke Joh; Hiroshi Tanaka
Journal:  Clin Exp Nephrol       Date:  2014-12-04       Impact factor: 2.801

5.  Influence of MX1 promoter rs2071430 G/T polymorphism on susceptibility to systemic lupus erythematosus.

Authors:  Suad AlFadhli; Mashael Al-Mutairi; Bader Al Tameemi; Rasheeba Nizam
Journal:  Clin Rheumatol       Date:  2016-01-27       Impact factor: 2.980

6.  Tumor necrosis factor-α synergistically enhances polyinosinic-polycytidylic acid-induced toll-like receptor 3 signaling in cultured normal human mesangial cells: possible involvement in the pathogenesis of lupus nephritis.

Authors:  Tadaatsu Imaizumi; Tomomi Aizawa; Ryo Hayakari; Fei Xing; Pengfei Meng; Kazushi Tsuruga; Tomoh Matsumiya; Hidemi Yoshida; Liang Wang; Tetsuya Tatsuta; Hiroshi Tanaka
Journal:  Clin Exp Nephrol       Date:  2014-03-14       Impact factor: 2.801

7.  Inhibitory effect of anti-malarial agents on the expression of proinflammatory chemokines via Toll-like receptor 3 signaling in human glomerular endothelial cells.

Authors:  Riko Sato; Tadaatsu Imaizumi; Tomomi Aizawa; Shojiro Watanabe; Koji Tsugawa; Shogo Kawaguchi; Kazuhiko Seya; Tomoh Matsumiya; Hiroshi Tanaka
Journal:  Ren Fail       Date:  2021-12       Impact factor: 2.606

8.  Whole-genome transcription and DNA methylation analysis of peripheral blood mononuclear cells identified aberrant gene regulation pathways in systemic lupus erythematosus.

Authors:  Honglin Zhu; Wentao Mi; Hui Luo; Tao Chen; Shengxi Liu; Indu Raman; Xiaoxia Zuo; Quan-Zhen Li
Journal:  Arthritis Res Ther       Date:  2016-07-13       Impact factor: 5.156

9.  GBP2 acts as a member of the interferon signalling pathway in lupus nephritis.

Authors:  Yuan Zhang; Yinping Liao; Qing Hang; Dong Sun; Ya Liu
Journal:  BMC Immunol       Date:  2022-09-17       Impact factor: 3.594

Review 10.  Interferon pathway in SLE: one key to unlocking the mystery of the disease.

Authors:  Lars Rönnblom; Dag Leonard
Journal:  Lupus Sci Med       Date:  2019-08-13
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.